Pharm Sci Seminar – Libin Xu, PhD
Small molecule drugs mostly have molecular weight of less than 500, but they exert large structural diversity as they bind to various drug targets. Drug metabolism by Phase-I and Phase-II enzymes further increases such structural diversity.